Under the agreement IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by aTen.

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs.

Point-of-care test for detection of infection in patients on peritoneal dialysis available in France, Germany, Italy, The Netherlands, Austria and Switzerland.

Protein Metrics Inc., a leading provider of mass spectrometry software for protein characterization, has introduced the Byos™ platform, which automates biotherapeutic characterization workflows with just one click.

Comprehensive registration system offers new capabilities that enhance intellectual property protection and supports emerging methodologies in biologic drug discovery.

The Thermo Scientific Orion Star T900 Series is designed to automate QC/QA processes and boost efficiency.

High-resolution imaging and elemental analysis permit fast, accurate characterization of powdered raw materials and inspection of finished parts.

The major aim during the multi-passage cultivation of pluripotent stem cells (PSCs) is to preserve their differentiation and growth potential. Here, the proper selection of a defined culture system that consists of a growth surface and culture medium is crucial.

Oppilotech Ltd, a biopharmaceutical company founded to develop safe, first-in-class, antibacterial therapies, announced it has been selected for funding by Innovate UK – the UK’s innovation agency.

Stronger strategic investments for further sustainable growth.